Benznidazole treatment in chronic children infected with Trypanosoma cruzi: Serological and molecular follow-up of patients and identification of Discrete Typing Units

Acta Tropica

Volumn 128, Issue 1, 2013, Pages 130-136

  Rumi, M M Monje ^a   Perez Brandan C ^a   Gil, J F ^a   D'Amato, A M Alberti ^a   Ragone, P G ^a   Lauthier, J J ^a   Tomasini, N ^a   Cimino, R O ^a   Orellana, V ^a   Lacunza, C D ^a   Nasser, J R ^a   Basombrio M A ^a   Diosque, P ^a  

^a UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

Benznidazole; Chagas disease; DTUs; Hybridization; PCR; Serology

Indexed keywords

BENZNIDAZOLE; MINICIRCLE DNA;

BIOASSAY; CHAGAS DISEASE; CHILD HEALTH; DISEASE TREATMENT; DNA; HEALTH RISK; HEMOPARASITE; HYBRIDIZATION; IMMUNOASSAY; POLYMERASE CHAIN REACTION;

ADOLESCENT; ARGENTINA; ARTICLE; CHAGAS DISEASE; CHILD; COLIC; CONTROLLED STUDY; DIARRHEA; DISCRETE TYPING UNIT; DNA DETERMINATION; DNA HYBRIDIZATION; DNA PROBE; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINICIRCLE HYPERVARIABLE REGION; MOLECULAR GENETICS; PARESTHESIA; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SEROCONVERSION; SERODIAGNOSIS; SKIN ALLERGY; TREATMENT DURATION; TRYPANOSOMA CRUZI; VOMITING;

ARGENTINA;

TRYPANOSOMA CRUZI;

BENZNIDAZOLE; CHAGAS DISEASE; DTUS; HYBRIDIZATION; PCR; SEROLOGY;

ADOLESCENT; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; ARGENTINA; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DNA, KINETOPLAST; DNA, PROTOZOAN; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; NITROIMIDAZOLES; NUCLEIC ACID HYBRIDIZATION; RURAL POPULATION; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

EID: 84883742535     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.07.003     Document Type: Article

References (41)

1. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
2. Ávila H., Gonçalves A.M., Nehme N.S., Morel C.M., Simpson L. Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable regions sequences. Molecular and Biochemical Parasitology 1990, 42:175-188.
3. Belluzo M.S., Ribone M.E., Camussone C., Marcipar I.S., Lagier C.M. Favorably orienting recombinant proteins to develop amperometric biosensors to diagnose Chagas' disease. Analytical Biochemistry 2011, 408:86-94.
4. Burgos J.M., Altcheh J., Bisio M., Duffy T., Valadares H.M., Seidenstein M.E., Piccinali R., Freitas J.M., Levin M.J., Macchi L., Macedo A.M., Freilij H., Schijman A.G. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. International Journal for Parasitology 2007, 37:1319-1327.
5. Cardinal M.V., Lauricella M.A., Ceballos L.A., Lanati L., Marcet P.L., Levin M.J., Kitron U., Gurtler R.E., Schijman A.G. Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina. International Journal for Parasitology 2008, 38:1533-1543.
6. Coronado X., Zulantay I., Rozas M., Apt W., Sanchez G., Rodriguez J., Ortiz S., Solari A. Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole. Journal of Antimicrobial Chemotherapy 2006, 58:216-219.
7. Corrales R.M., Mora M.C., Negrette O.S., Diosque P., Lacunza D., Virreira M., Breniere S.F., Basombrio M.A. Congenital Chagas disease involves Trypanosoma cruzi sub-lineage IId in the northwestern province of Salta, Argentina. Infection, Genetics and Evolution 2009, 9:278-282.
8. Coura J.R., Borges-Pereira J. Chagas disease. What is known and what should be improved: a systemic review. Revista da Sociedade Brasileira de Medicina Tropical 2012, 45:286-296.
9. Cura C.I., Lucero R.H., Bisio M., Oshiro E., Formichelli L.B., Burgos J.M., Lejona S., Bruses B.L., Hernandez D.O., Severini G.V., Velazquez E., Duffy T., Anchart E., Lattes R., Altcheh J., Freilij H., Diez M., Nagel C., Vigliano C., Favaloro L., Favaloro R.R., Merino D.E., Sosa-Estani S., Schijman A.G. Trypanosoma cruzi Discrete Typing Units in Chagas disease patients from endemic and non-endemic regions of Argentina. Parasitology 2012, 139:516-521.
10. de Andrade A.L., Zicker F., de Oliveira R.M., Almeida Silva S., Luquetti A., Travassos L.R., Almeida I.C., de Andrade S.S., de Andrade J.G., Martelli C.M. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996, 348:1407-1413.
11. Di Rienzo J., Casanoves F., Balzarini M., Gonzales L., Tablada M., Robledo O. InfoStat Versión 2009 2009, Grupo InfoStat, FCA, Universidad Nacional de Córdoba, Argentina.
12. Diez C., Lorenz V., Ortiz S., Gonzalez V., Racca A., Bontempi I., Manattini S., Solari A., Marcipar I. Genotyping of Trypanosoma cruzi sublineage in human samples from a North-East Argentina area by hybridization with DNA probes and specific polymerase chain reaction (PCR). The American Journal of Tropical Medicine and Hygiene 2010, 82:67-73.
13. Diosque P., Barnabe C., Padilla A.M., Marco J.D., Cardozo R.M., Cimino R.O., Nasser J.R., Tibayrenc M., Basombrio M.A. Multilocus enzyme electrophoresis analysis of Trypanosoma cruzi isolates from a geographically restricted endemic area for Chagas' disease in Argentina. International Journal for Parasitology 2003, 33:997-1003.
14. Diosque P., Padilla A.M., Cimino R.O., Cardozo R.M., Negrette O.S., Marco J.D., Zacca R., Meza C., Juarez A., Rojo H., Rey R., Corrales R.M., Nasser J.R., Basombrio M.A. Chagas disease in rural areas of Chaco Province, Argentina: epidemiologic survey in humans, reservoirs, and vectors. The American Journal of Tropical Medicine and Hygiene 2004, 71:590-593.
15. Escriba J.M., Ponce E., Romero Ade D., Vinas P.A., Marchiol A., Bassets G., Palma P.P., Lima M.A., Zuniga C., Ponce C. Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras. Memórias do Instituto Oswaldo Cruz 2009, 104:986-991.
16. Flores-Chavez M., Bosseno M.F., Bastrenta B., Dalenz J.L., Hontebeyrie M., Revollo S., Breniere S.F. Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II. The American Journal of Tropical Medicine and Hygiene 2006, 75:497-501.
17. Galvao L.M., Chiari E., Macedo A.M., Luquetti A.O., Silva S.A., Andrade A.L. PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. Journal of Clinical Microbiology 2003, 41:5066-5070.
18. Guedes P.M., Silva G.K., Gutierrez F.R., Silva J.S. Current status of Chagas disease chemotherapy. Expert Review of Anti-Infective Therapy 2011, 9:609-620.
19. Laucella S.A., Mazliah D.P., Bertocchi G., Alvarez M.G., Cooley G., Viotti R., Albareda M.C., Lococo B., Postan M., Armenti A., Tarleton R.L. Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy. Clinical Infectious Diseases 2009, 49:1675-1684.
20. Marin-Neto J.A., Rassi A., Avezum A., Mattos A.C., Rassi A., Morillo C.A., Sosa-Estani S., Yusuf S. The benefit trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz 2009, 104:319-324.
21. Mejia-Jaramillo A.M., Fernandez G.J., Montilla M., Nicholls R.S., Triana-Chavez O. Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia. Biomédica 2012, 32:196-205.
22. Mitelman J.E., Descalzo A., Gimenez L., Pesce R., Villanueva H.R. Consensus statement on Chagas-Mazza disease. Revista Argentina de Cardiologia 2011, 79:544-564.
23. Moreno M., D'Avila D A., Silva M.N., Galvao L.M., Macedo A.M., Chiari E., Gontijo E.D., Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memórias do Instituto Oswaldo Cruz 2010, 105:918-924.
24. Murta S.M., Gazzinelli R.T., Brener Z., Romanha A.J. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Molecular and Biochemical Parasitology 1998, 93:203-214.
25. Palacios X., Belli A., Espino A.M. Detección de anticuerpos contra Trypanosoma cruzi en Somoto, Nicaragua mediante ELISA indirecto e IFI en muestras de sangre en papel de filtro. Revista Panamericana de Salud Pública 2000, 8:411-417.
26. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
27. Schijman A.G., Altcheh J., Burgos J.M., Biancardi M., Bisio M., Levin M.J., Freilij H. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. Journal of Antimicrobial Chemotherapy 2003, 52:441-449.
28. Schijman A.G., Bisio M., Orellana L., Sued M., Duffy T., Mejia Jaramillo A.M., Cura C., Auter F., Veron V., Qvarnstrom Y., Deborggraeve S., Hijar G., Zulantay I., Lucero R.H., Velazquez E., Tellez T., Sanchez Leon Z., Galvao L., Nolder D., Monje Rumi M., Levi J.E., Ramirez J.D., Zorrilla P., Flores M., Jercic M.I., Crisante G., Anez N., De Castro A.M., Gonzalez C.I., Acosta Viana K., Yachelini P., Torrico F., Robello C., Diosque P., Triana Chavez O., Aznar C., Russomando G., Buscher P., Assal A., Guhl F., Sosa Estani S., DaSilva A., Britto C., Luquetti A., Ladzins J. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Neglected Tropical Diseases 2011, 5:e931.
29. Silveira C.A., Castillo E., Castro C. Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase. Revista da Sociedade Brasileira de Medicina Tropical 2000, 33:191-196.
30. Solari A., Campillay R., Ortiz S., Wallace A. Identification of Trypanosoma cruzi genotypes circulating in Chilean chagasic patients. Experimental Parasitology 2001, 97:226-233.
31. Solari A., Ortiz S., Soto A., Arancibia C., Campillay R., Contreras M., Salinas P., Rojas A., Schenone H. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. Journal of Antimicrobial Chemotherapy 2001, 48:515-519.
32. Sosa-Estani S., Viotti R., Segura E.L. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Memórias do Instituto Oswaldo Cruz 2009, 104:167-180.
33. Sosa Estani S., Segura E.L., Ruiz A.M., Velazquez E., Porcel B.M., Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. The American Journal of Tropical Medicine and Hygiene 1998, 59:526-529.
34. Souza R.M., Amato Neto V. Discrepancies and consequences of indirect hemagglutination, indirect immunofluorescence and ELISA tests for the diagnosis of Chagas disease. Revista do Instituto de Medicina Tropical de Sao Paulo 2012, 54:141-143.
35. Streiger M., del Barco M., Fabbro D., Arias E., Amicone N. Estudo longitudinal e quimioterapia específica em crianças com doença de Chagas crÔnica, residentes em área de baixa endemicidade da República Argentina. Revista da Sociedade Brasileira de Medicina Tropical 2004, 37:365-375.
36. Tarleton R.L., Zhang L. Chagas disease etiology: autoimmunity or parasite persistence?. Parasitol Today 1999, 15:94-99.
37. Veas F., Breniere S.F., Cuny G., Brengues C., Solari A., Tibayrenc M. General procedure to construct highly specific kDNA probes for clones of Trypanosoma cruzi for sensitive detection by polymerase chain reaction. Cell and Molecular Biology 1991, 37:73-84.
38. Viotti R., Vigliano C., Alvarez M.G., Lococo B., Petti M., Bertocchi G., Armenti A., De Rissio A.M., Cooley G., Tarleton R., Laucella S. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Neglected Tropical Diseases 2011, 5:e1314.
39. WHO Reporte sobre Enfermedad de Chagas. Programa Especial de Investigaciones y Enseñanzas sobre Enfermedades Tropicales(TDR) 2005, 1-97. World Health Organization Expert Committee 2005, Buenos Aires,Argentina.
40. WHO World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR). Report of Scientific Group in Chagas disease 2007, (Update July 2007).
41. Wincker P., Bosseno M., Britto C., Yaksic N., Cardoso M., Morel C., Brenière S. High correlation between Chagas' disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area. FEMS Microbiology Letters 1994, 124:419-423.